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CHAPTER 1. INTRODUCTION
1.1 Alternative Medicine Delivery Systems Research
One problem with modern medicine is that oral-based or injection-based delivery
results in the medicine spreading over the entire body rather than concentrating in the
area it needs to go. Not only does this lead to the unpleasant side effects medicine is
known for, but much of the medicine is essentially wasted outside of where it needs to be.
Research is currently underway for alternative delivery methods that will allow the
chemicals to reach their target without having to flood the entire body with the substance
or expose the medicine directly to potentially hostile internal environments prior to its
intended destination. The method that is the focus of this paper is the usage of
amphiphilic copolymers encapsulating nanoparticles.

1.2 In-Depth Look at Structure
As the name implies, the primary structure consists of a copolymer forming a
capsule enclosing a nanoparticle that the chemist wants to deliver into the cells of an
organism. The monomers selected to form the copolymer were poly(ethylene glycol) and
the amino acid L-Leucine. Poly(ethylene glycol) serves as the hydrophilic exterior of the
capsule in aqueous environments and is known for its biocompatibility, so it will protect
what it contains from being destroyed by the organism’s immune systems.[1] In fact,
poly(ethylene glycol) has already been used in several studies for pharmaceutical and
research purposes where an immune response targeting the active component is not
desirable.[2][3][4] Figure 1 shows the structure of unmodified poly(ethylene glycol).

Figure 1.1: The Structure of Poly(Ethylene Glycol)
L-Leucine is a nonpolar amino acid that prefers to aggregate with itself away from
polar environments. As with other amino acids, L-Leucine can be polymerized to form
the poly(amino acid) known as poly(L-Leucine). Poly(L-Leucine) is used in this study to
form a copolymer with poly(ethylene glycol). This copolymerization retains the
respective hydrophilicity and hydrophobicity of the two polymers, which in turn allows
for the copolymer to aggregate with a hydrophilic exterior from the poly(ethylene glycol)
and a hydrophobic interior with poly(L-Leucine).[5] Poly(amino acids) also possess a high
degree of biocompatibility and are usually synthesized through the formation of Ncarboxyanhydride (NCA) rings to facilitate ring-opening polymerization.[6] The structure
of a single leucine amino acid is shown in Figure 2, but polymerized leucine connects the
individual amino acids by attaching them through their amine and carboxylic acid groups.

Figure 1.2: The Structure of L-Leucine
1.3 Monomer Synthesis
The process used to form NCA rings was the Fuchs-Farthing method, wherein the
amino acid is phosgenized to form the five-membered NCA ring.[7] This process is shown
in Figure 3.
2

Figure 1.3: Formation of an NCA Ring from an Amino Acid via the Fuchs-Farthing
Method. (R indicates an Amino Acid Chain. * indicates a Chiral Carbon.)
As the name implies, ring-opening polymerization requires the opening of the
NCA ring. This opening can be initiated with an amine group, so once it starts, the
polymerization will easily continue so long as amino acids are available.[8] Unfortunately,
the unmodified form of polyethylene glycol possesses no amine group, so it must be
modified to have one. In the course of the synthesis, multiple variations on poly(ethylene
glycol) were used. The selected variations were α-methoxy-ω-amino poly(ethylene
glycol), or mPEG; α-amino-ω-hydroxyl poly(ethylene glycol), or HO-PEG; and
poly(ethylene glycol) diamine, or PEG diamine. The structures of these variations are
shown in Figure 4.

Figure 1.4: The Structures of mPEG, HO-PEG, and PEG diamine

3

1.4 Polymerization
Since the variations possess amine groups, they can initiate ring-opening
polymerization of leucine. The PEG is fully synthesized to its intended length
beforehand, so a specific number of monomers can be selected for. Ring-opening
polymerization is a living polymerization, so the process will use all available leucine
amino acids. This process makes leucine the limiting factor. As such, the final number of
monomers for poly(L-Leucine) can be controlled as well, allowing for experimentation
on the effect of the lengths of the two individual polymers of the copolymer have on the
final size of the formed micelle. The scheme for the ring-opening polymerization of
poly(L-Leucine) onto a previously synthesized mPEG chain of length n is shown in
Scheme 1.
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Scheme 1.1: Ring-Opening Polymerization of Poly(L-Leucine) onto the Poly(Ethylene
Glycol) Variant Known as mPEG. (The three arrows in the final step represent a
repetition of the previous steps until the poly(L-Leu) chain achieves a length of x.)

The result of the ring-opening polymerization is a block copolymer with two
distinct blocks of poly(ethylene glycol) and poly(L-Leucine), which makes it an AB
block copolymer with the formula mPEGn-b-p(L-Leu)x where n and x are the number of
monomers for their respective polymers. HO-PEGn-b-p(L-Leu)x is also an AB block
copolymer formed from a scheme similar to mPEGn-b-p(L-Leu)x with ring-opening
polymerization. The only difference between the two is that the methyl group that forms
one end of mPEGn-b-p(L-Leu)x is replaced by a hydrogen. Even though this difference is
very small, especially when the polymers run into lengths of hundreds of monomers long,
this change in one terminal end of the AB block copolymer may impact the amphiphilic
5

nature of said copolymer by increasing that end’s hydrophilicity. However, while both
mPEG and HO-PEG produce AB block copolymers, poly(ethylene glycol) diamine does
not. The scheme for the ring-opening polymerization of poly(L-Leucine) onto
poly(ethylene glycol) diamine is shown in Scheme 2.

Scheme 1.2: Ring-Opening Polymerization of Poly(L-Leucine) onto Poly(Ethylene
Glycol) Diamine.
(The three arrows in the final step represent a repetition of the previous three
steps until both of the poly(L-Leu) chains achieve a chain length of x)

6

Because poly(ethylene glycol) diamine possesses two amine groups on either end,
the polymer will start ring-opening polymerization on both ends. As it is also a living
polymerization, the process will go to completion. Also, for both poly(L-Leucine) chains
to be the same length as the chains on the previous AB block copolymers, there will be
twice as much poly(L-Leucine) used. This polymerization will thus result in three distinct
blocks from two distinct polymers, which forms an ABA block copolymer. This form of
block copolymer may consist of hydrophilic and hydrophobic regions but isn’t strictly
amphiphilic since both ends are hydrophobic. However, since the chain is flexible, it can
still act as an amphiphilic copolymer if it bends in half so that both hydrophobic poly(LLeucine) chains are in the interior of the micelle. Since this change in structure is
markedly different from the other two AB block copolymers, it is fully expected that the
ABA block copolymer p(L-Leu)x-b-PEGn-b-p(L-Leu)x will provide results for micelle
diameter that are markedly different from HO-PEGn-b-p(L-Leu)x micelles or mPEGn-bp(L-Leu)x micelles.

1.5 Self Assembly
As for the nanoparticle itself, a 5 nm diameter iron oxide nanoparticle was
selected for testing change in size for the product with and without the nanoparticle. This
does not preclude other kinds of nanoparticles that may be selected for future research in
areas such as radioactive marking or medicinal delivery.
When introduced to a polar solution, the aforementioned components of the
copolymer-encapsulated nanoparticle will arrange themselves as dictated by natural
forces. This process is known as self-assembly.[9] Self-assembly is one of the major

7

advantages of diblock-copolymer encapsulated nanoparticles. The hydrophilic polymer of
poly(ethylene glycol) will form the outermost layer of the micelle, and the hydrophobic
poly(L-Leucine) will aggregate in the interior along with the nanoparticle selected for
containment within the micelle.[10] To minimize the influence of factors not accounted
for, self-assembly was always carried out at 25 degrees Celsius in a solvent of distilled
water. As shown in Figure 5, the resultant structure is stable and highly organized.

Figure 1.5: The Organized Self-Assembly of Block Copolymer Micelles in Aqueous
Solution
According to a study from 2017, the morphology adopted by the micelle upon
self-assembly is decided by a variable known as the packing parameter p = v/a0lc, where
v is the volume of the hydrophobic chain, a0 is the optimal area of the head group, and lc
is the length of the hydrophobic chain.[9] The smaller the packing parameter is, the
smaller the structure formed from the self-assembly. A larger packing parameter will
produce a larger structure. The primary reason for this relationship between packing
parameter and structure, is that the packing parameter is also a measurement of the

8

structure’s curvature. As shown in Figure 6 and Figure 7, the various structures come
about because of the specific ratio of the hydrophobic and hydrophilic chains.

Figure 1.6: Possible Morphologies for Diblock Copolymer That are Decided by the
Packing Parameter. (Reproduced with permission from Feng, et al.[9])

Figure 1.7: Packing Parameter (P) as a Measure of the Curvature of the Self-Assembled
Structure of an Amphiphilic Diblock Copolymer. (Reproduced with permission from
Feng, et al.[9])
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The work conducted in the present study focused exclusively on producing
spherical micelles of less than 100nm in diameter. This is because the small, simple
structures are easily absorbed by cells and can penetrate biological barriers to facilitate
delivery of their contents.[11] Larger, more complex structures might not penetrate
biological barriers as easily due to their increased size. Spherical micelles form with a
high curvature and a small packing parameter according to Figure 7. According to the
packing parameter formula, a long hydrophobic chain and a large head area will shrink
the packing parameter and increase curvature. As such, an increase in the monomers of
the hydrophobic chain or the hydrophilic chain or both should decrease the packing
parameter and increase curvature to a point, causing the micelles to decrease in size.
However, if the lengths are increased too much, a different structure would form. For this
study, all copolymer lengths are kept within the ranges that form spherical micelles.
Since block copolymer micelles are not alive, they do not have the capacity to
infect target cells like bacteria and other microorganisms. Rather, the process the micelles
use is known as extravasation. Extravasation is defined as the movement of fluids or cells
from the blood vessels into the surrounding tissues, and often includes interactions
between cells mediated via chemotactic signals.[12] Amphiphilic block copolymer
micelles are designed to be absorbed by their target cells without activating an immune
response, so modifying an amphiphilic block copolymer with these chemotactic signals
would allow for extravasation from the bloodstream as well. Furthermore, research into
copolymeric micellular delivery systems has already shown extremely promising results
for tumor treatment due to the enhanced permeability and retention (EPR) effect
displayed by said tumors.[13] While this research mainly used the delivery system to

10

deliver MRI contrast agents to the tumor, there is no reason to assume that the EPR effect
couldn’t also be taken advantage of to deliver other substances to the tumor cells. In fact,
the ability of these micelles’ effectiveness in extravasation was also used in research of
macromolecules crossing the blood-brain barrier after cerebral injuries.[14] It was already
known that the micelles containing the MRI imaging could cross the barrier, for they
were used to keep track of the macromolecules’ movements.[14] As such, there is no
question that the amphiphilic copolymer micelles can penetrate biological barriers. Now
the question lies in whether or not these micelles are outclassed by other forms of
medicine delivery already.

1.6 Main Advantages of Co-Polymer Encapsulated Nanoparticles
Other methods being researched utilize bioengineered microorganisms such as
bacteria to deliver the medicine into the body, but this research comes with an inherent
risk in that microorganisms tend to mutate in a short period of time, so an engineered
organism designed specifically to enter humans could become quite a problem.[15]
Copolymer-encapsulated nanoparticles are not alive and thus have no ability to mutate
into forms they are not designed to be. Another issue with some medicines and most
microorganisms is that they elicit an immune response from the body. Bioengineered
bacteria utilize the infectious nature of the very microorganisms to transport medicine to
where it is supposed to be, but that very ability to infect may result in the body building
an immune response to the nanomedicine delivery.[16] This situation will result in loss of
medicine as the body attacks both container and cargo just as if it was a pathological
microorganism. While it is useful for vaccinations, there are many other situations where

11

the medicine must avoid being destroyed by the immune system so it can reach the
targeted area. Furthermore, the immune response may result in discomforting side effects
for the person since the body will treat the nanomedicine as an infection. The materials
that were selected for the copolymer will not trigger a large immune response due to their
biocompatibility, which will reduce side effects caused by activation of the immune
system and prevent loss of delivered material.
Other research has investigated the usage of viral vectors for drug delivery instead
of the aforementioned bacterial vectors.[14] However, these vectors still possess the same
problems as before. The immune system is still likely to react to the delivery method as
the package is a virus. Furthermore, there is always a danger of mutations in
microorganisms, and this is especially true for viruses. New forms of disease could easily
come about if there is an error in preparing the viral vector. Furthermore, other research
has also called into question the cost effectiveness of bioengineered microorganisms as
drug delivery vectors.[17] If there is a danger of mutation and the cost is higher and the
immune system will still interfere with delivery, then the advantages of amphiphilic
block copolymer micelle encapsulated nanoparticles over these bacterial and viral vectors
are clear. As such, research into the amphiphilic block copolymers is highly
recommended for both cost and safety reasons.
With the materials selected and a desired size for the final product of the diblock
copolymer micelles, several variations of the diblock copolymer were synthesized with
different lengths of PEG variants and polyleucine in preparation for the self-assembly.
The experimental section will detail the process of setting up the self-assembly and how
the results were obtained from the product.
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CHAPTER 2. EXPERIMENTAL
2.1 Materials
The various variations of diblock copolymer utilized in this research into the
effect of copolymer length on micelle size were synthesized in previous work.[18] Iron
oxide nanoparticles of 5nm in diameter were obtained from Ocean Nanoparticles in San
Diego, California. Storage of the iron oxide nanoparticles was carried out with Eppendorf
tubes stored in a fridge at 5°C. These nanoparticles were dissolved in chloroform when
stored, but the chloroform was allowed to dry off when the nanoparticles used in the
experiment so that the chemical would not be present in later solutions. Tetrahydrofuran
(THF) was provided by Alfa Aesar. The thermodyne was obtained from Barnstead. The
vortex used was obtained from Fisher Scientific. A Nano-ZS model Zetasizer was
obtained from Malvern Panalytical.

2.2 Methods
2.2.1 Assembly of Block Polymer Encapsulated Nanoparticle
All metal spatulas used for handling the copolymer directly were stored in an
oven at 80°C prior to use in experiment. All glassware would be thoroughly cleaned and
dried as well. At first, the copolymers were assembled without nanoparticles to obtain
their diameters when empty. Later iron oxide nanoparticles were utilized where 10 uL of
5nm iron oxide nanoparticle were transferred from their Eppendorf tube to a disposable
plastic vial. After the nanoparticle was allowed to dry, if it was present, ~1 mg of a
selected diblock copolymer was weighed and then added to the disposable vial. Then
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1000 uL of THF was added to the disposable vial, which was then closed and shaken
until all the solid contents had visibly dissolved into the THF. Figure 8 displays the
appearance of the vial at this point in the experiment if no iron oxide was being used for
that specific trial.

Figure 2.1: The Regular Appearance of Amphiphilic Copolymer Dissolved in THF is
Clear. Iron Oxide Would Lend an Orange Cloudy Color to This Liquid.
When there was no discernable solid left in the solution of THF, the contents of
the disposable vial were transferred to a glass syringe fitted with a nylon 0.2 micrometer
syringe driven filter and filtered into a second disposable plastic vial. It was very
important not to press too hard on the syringe’s plunger while filtering the THF, or else
the filter itself would rupture, releasing all the unfiltered contents into the vial along with
whatever pieces of the filter came off. The purpose of the filtration was to remove all
particles and aggregates that were above a certain diameter, so that the remainder was
within the desired range. Any later results for diameter above 200 nm would indicate that
the materials in the filtered solution had aggregated to that higher diameter. To maximize
the possibility that all of the nanoparticles pass through the filter, some additional pure
THF could be added to the glass syringe to ensure that at least 1000 uL of filtered THF
solution would be present in the second disposable vial. Figure 9 displays the contents of
the vial from Figure 4 after they have been filtered in such a manner.
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Figure 2.2: Filtered THF Diblock Copolymer Solution Displays No Change in
Appearance Whether With or Without Nanoparticle
In preparation for the next step, 1mL of distilled water was added to a 20 mL
glass vial. A line was drawn at the current level of the meniscus. Then, through usage of a
glass pipette and a plastic bulb, the filtered THF solution was added dropwise to the 20
mL vial while the 20 mL vial was being agitated by a thermodyne. The Maxi Mix Plus
thermodyne from Barnstead that was used in lab is shown in Figure 10. The fully
transferred solution is shown in Figure 11.

Figure 2.3: This Thermodyne was Used to Ensure that the Dropwise Addition of THF
Solution to Water Would Result in a Mixture and Not Separate Layers
15

Figure 2.4: THF Solution Fully Added to Distilled H2O Still Maintains No Coloration
Once all of the THF solution was transferred, the solution was left on a slowly
shaking vortex overnight so that the THF could evaporate out of solution while the
agitation ensured that the diblock copolymer capsules stayed suspended in said solution.
The vortex from Fisher is shown in Figure 12.

Figure 2.5: The Vortex Utilized to Keep Solutions Agitated for 24 Hours. Preferred
Setting for this Procedure was Shake, not Vortex.

2.2.2 Determination of Diameter via Zetasizer
After 24 hours had elapsed, the vial was examined to determine the level of fluid
inside. If the meniscus had returned to the level of the mark made previously, then the
16

THF had evaporated leaving the diblock copolymer encapsulated nanoparticles
suspended in water. The contents of the vial were then transferred to a disposable cuvette
and then placed in a zetasizer. The zetasizer is shown in Figure 13.

Figure 2.6: The NanoZS Zetasizer Model was Used to Determine Diameter of the
Encapsulated Nanoparticles in Solution
One of the features of this model of zetasizer is that it doesn’t just measure zeta
potential, it can also determine the diameter of the particles suspended in solution. In its
usage, each separate solution was measured five times at 25°C with a 173° angle
backscatter for the light beam. Polydispersity index (PDI) was also obtained as a measure
of the accuracy of the results and the consistency of the mixture for each separate
measurement of the amphiphilic copolymer encapsulated nanoparticles’ diameters.
However, the results shown in the Results and Discussion section contain data where the
PDI is consistently below 0.5. As such, the focus will be on the diameter measurements,
because the solutions are not varying the measurement to the point of invalidating said
measurements.
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CHAPTER 3. RESULTS AND DISCUSSION
The self-assembly of PEG-b-p(L-Leu) with varying p(L-Leu) chain lengths was
studied with and without the encapsulation of magnetic Fe3O4 nanoparticles. Fe3O4, also
known as iron oxide or magnetite, can serve as a contrasting agent in magnetic resonance
imaging applications when radiolabeled with an element such as Gallium-68.[19] The
radiolabeling can also serve to effect radiation therapy for the treatment of tumors.[20]
These magnetic nanoparticles have also found applications outside of magnetic resonance
imaging, such as in the repair of bone tissue, where their magnetic properties can be
utilized with a magnetic field to physically stimulate the cells they’ve been absorbed
into.[21] Therefore, iron oxide nanoparticles have numerous useful applications in ongoing
medical research. However, this only holds true if the iron oxide nanoparticles are
delivered to their correct target cells for whatever procedure they are being used for.
Intravenous injection of these nanoparticles can lead to unpleasant side effects. While not
as cytotoxic as gold nanoparticles, iron oxide nanoparticles can still elicit a response from
white blood cells in the immune system.[19] Furthermore, if these iron oxide nanoparticles
have been radiolabeled for use in radiation therapy, intravenous injection doesn’t
guarantee that the targeted tumor cells will be the only cells that absorb the radioactive
nanoparticles. Since the goal of radiation treatment is to destroy cancerous tissue and not
healthy tissue, this is obviously a flaw. In other words, iron oxide nanoparticles have
various uses in medical research, but this usefulness could be vastly improved if these
nanoparticles could be shielded from the immune system or could directly and
exclusively target their target cells.
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This is where polymeric micelle medicine delivery systems come into the picture.
Amphiphilic block copolymer micelles made from poly(ethylene glycol) and poly(LLeucine) do not elicit an immune response and can effectively shield their contents.[1] [6]
Furthermore, these micelles have been proven to allow for more direct and exclusive
targeting of target cells, and can penetrate biological barriers that iron oxide likely would
not be able to do so by itself.[11] [12] [13] The next logical step was to assemble the micelles
to encapsulate the nanoparticles in the pursuit of an amphiphilic block copolymer micelle
formed from poly(ethylene glycol) and poly(L-Leucine) that fully encapsulates iron oxide
nanoparticles while maintaining a diameter no larger than 100 nm. The assembly was
performed with three different variations of poly(ethylene glycol), and the data has been
organized into three different groups depending on which variation was used.

3.1 mPEGn-b-p(L-Leu)x Copolymer Diameter Data
Amphiphilic diblock copolymers formed by the ring-opening polymerization of
L-Leucine NCA onto mPEG were studied. Two lengths of mPEG were used. One was
mPEG45 and the other was mPEG113. This would allow for the data to be divided
according to whether the length of mPEG was short or long as well as the lengths effects
on micelle diameter size. For each length of mPEG, three lengths of poly(L-Leucine)
were used to account for its effects on the size of the resultant micelle. Finally, for the
micelles that formed under 100 nm in diameter, more assembly procedures were
conducted with the addition of iron oxide nanoparticles of 5nm in diameter. This would
provide data for block copolymer micelles with and without the nanoparticle. Manual
collection of the samples was simplest for these copolymer variants. Unlike later
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copolymers, these mPEG copolymers also displayed no static electrical attraction to
nearby surfaces. When introduced to THF, these copolymers readily and promptly
dissolved. After the THF had evaporated from the aqueous solution formed as per the
experimental, there were no unusual properties noted in the solution before or after
zetasizer measurement. The compiled data is shown in Table 1 and Table 2.
Table 3.1: Individual Measurements in Nanometers of Micelle Diameters Formed from
Copolymer Variations with 113 or 45 Monomeric Units of α-methoxy-ω-amino
polyethylene glycol (mPEG) and no 5 nm Nanoparticle
Tested Polymer
mPEG113 - p(L-Leu)22
mPEG113 - p(L-Leu)45
mPEG113 - p(L-Leu)65
mPEG45 - p(L-Leu)6
mPEG45 - p(L-Leu)20
mPEG45 - p(L-Leu)53

Trial 1 Trial 2 Trial 3 Trial 4 Trial 5
50.65 55.27
49.77 50.07 51.81
28.55 23.48
51.94 49.15 44.73
27.04 30.98
17.15 25.55 137.5
45.82
43.4
157.0

46.75
40.86
33.09

44.1
685.3
181.5

45.65
479.8
191.3

45.46
464.6
27.85

Table 3.2: Individual Measurements in Nanometers of Micelle Diameters Formed from
Copolymer Variations with 113 Monomeric Units of α-methoxy-ω-amino polyethylene
glycol (mPEG) and 5 nm Nanoparticles
Tested Polymer
mPEG113 - p(L-Leu)22
mPEG113 - p(L-Leu)45
mPEG113 - p(L-Leu)65

Trial 1 Trial 2 Trial 3 Trial 4 Trial 5
52.03
77.05
100.7
83.47
130.8
52.78
51.62
71.57
56.21
52.93
43.2
47.5
47.54
46.93
49.99

The five measurements for each variation of copolymer were averaged to find the
mean diameter for the micelles formed from each copolymer variation. Additionally, the
mass fractions of L-Leucine were calculated for the variations. This calculation allows for
a comparison between the micelle diameters and the mass fractions of L-Leucine. The
calculated average diameters and L-Leucine mass fractions are shown in Table 3 and
Table 4. It should be noted that the mass fractions of L-Leucine were not considered to
have changed with the addition of the nanoparticle. Please note that the fifth trial for
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mPEG113 - p(L-Leu)65 was not included in the calculations for the average as it was found
to be an outlier in the data.
Table 3.3: Average Diameters and L-Leucine Mass Fractions for mPEGn-b-p(L-Leu)x
Copolymer Micelles that did not Contain Nanoparticles
Tested Copolymers
mPEG113 - p(Leu)22
mPEG113 - p(Leu)45
mPEG113 - p(Leu)65
mPEG45 - p(L-Leu)6
mPEG45 - p(L-Leu)20
mPEG45 - p(L-Leu)53

Mass Fraction of
Polydispersity
Average Diameter Leucine
Index (PDI)
0.267
51.51 nm
33.01%
0.39
39.57 nm
50.20%
0.227
20.14 nm
59.28%
45.56 nm
342.8 nm
118.5 nm

25%
53%
78%

0.374
0.496
0.410

Table 3.4: Average Diameters and L-Leucine Mass Fractions for mPEGn-b-p(L-Leu)x
Copolymer Micelles that were Made With 10 uL of 5 nm Nanoparticles per 1mL of
Aqueous Solution
Tested Copolymers
mPEG113 - p(Leu)22
mPEG113 - p(Leu)45
mPEG113 - p(Leu)65

Mass Fraction of
Polydispersity
Average Diameter Leucine
Index (PDI)
0.28
88.81 nm
33.01%
0.28
57.02 nm
50.20%
0.318
47.03 nm
59.28%

With a simple comparison between average diameters and L-Leucine amounts,
two scatterpoint charts were made using Microsoft Excel to provide visual aid in analysis
of data trends. The first chart compares the mean micelle diameters in its y-axis with the
number of L-Leucine micelles in their respective copolymer variations in the x-axis. The
second chart displays a similar comparison, but the x-axis is the mass fraction of LLeucine in the copolymer’s total weight rather than the number of monomeric units.
These charts are shown as Figure 14 and Figure 15.

21

L-Leucine Count vs. Micelle Diameter for mPEG Copolymers
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Figure 3.1A: A Direct Comparison of Mean mPEGn-b-p(L-Leu)x Copolymer Micelle
Diameter with the Number of L-Leucine Monomers

L-Leucine Count vs. Micelle Diameter for mPEG Copolymers
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Figure 3.1B: mPEG113-b-p(L-Leu)x Data From Figure 14 Shown to Display Decrease in
Micelle Diameter
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Figure 3.2A: Comparison of Mean mPEGn-b-p(L-Leu)x Copolymer Micelle Diameter
with the Mass Fraction of L-Leucine

L-Leucine Mass Fraction vs. Micelle Diameter for mPEG
Copolymers
Micelle Diameter (nm)

140
120
100

88.81

80
60
40

57.02
51.51

39.57

20
0
20.00%

47.03

20.14
30.00%

40.00%

50.00%

60.00%

70.00%

80.00%

L-Leucine Mass Fraction
mPEG113

mPEG113 + 5 nm nanoparticle

Figure 3.2B: mPEG113-b-p(L-Leu)x Data from Figure 15 Shown to Display Decrease in
Micelle Diameter
When comparing the data according to the lengths of mPEG used, it becomes
clear from looking at Figure 14 and Figure 15 that the micelles assembled with mPEG45b-p(L-Leu)x copolymers are generally much larger in diameter than the micelles
assembled with mPEG113-b-p(L-Leu)x copolymers. This is not unexpected. The relatively
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short length of the hydrophilic mPEG45 leads to said polymer chain being unable to
adequately cover the hydrophobic interior unless more of it aggregates. However, each
new chain of mPEG brings with it more poly(L-Leucine) to form a larger hydrophobic
interior. Each new addition serves to escalate the size of the final product. The results for
the longer length of mPEG113 are also not unexpected for the same reasons. The smaller
diameter from the resultant micelle can be attributed to the mPEG113 being more adequate
to shield the hydrophobic interior without having to aggregate many separate copolymer
chains. With fewer chains being used, the resultant mPEG113-b-p(L-Leu)x micelles
possess smaller diameters about one-tenth the size of comparable mPEG45-b-p(L-Leu)x
micelles. The copolymer mPEG45-b-p(L-Leu)6 is an exception to this trend. The small
size of the monomers allowed for smaller aggregations to form compared to later forms
of mPEG45-b-p(L-Leu)x copolymers.
The data can be further analyzed according to the length of poly(L-Leucine) used
in the block copolymer micelle assembly process. With an increasing poly(L-Leucine)
chain length, the diameter of the mPEGn-b-p(L-Leu)x copolymer micelles decreases. This
is as expected. Poly(L-Leucine) will aggregate when introduced to an aqueous
environment. As the poly(L-Leucine) chain length increases, there will be more
hydrophobic interactions for aggregation, which will result in a more tightly packed p(LLeu) core for the resultant micelle. The attached mPEG will form the outer layer of the
copolymer. If there is a small amount of poly(L-Leucine) for each strand of copolymer,
then the final product will still have a certain amount of poly(L-Leucine), but there will
be an increase in the amount of mPEG. This occurs because each poly(L-Leucine) chain
is copolymerized with a mPEG chain, so with an increasing number of individual chains
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of poly(L-Leucine) required to reach aggregate size, more mPEG chains are being
brought in. However, it should be noted that the effect the length of poly(L-Leucine) has
on the diameter of the micelle is simply not as large as the effect of the length of mPEG.
Figure 15 adequately demonstrates this relationship, for even when the chain length of
poly(L-Leucine) is roughly identical between mPEG45 and mPEG113, it is abundantly
clear that the size of the micelles’ diameters are more effected by length of mPEG than
length of poly(L-Leucine).
The data presented in Table 1 through Table 4 also shows that mPEG113
copolymers clearly maintain a small size below 100 nm in diameter, with the smallest
diameter recorded being 17.15nm belonging to mPEG113-b-p(L-Leu)65 without the 5nm
iron oxide nanoparticle in Table 1. Given that the amphiphilic block copolymer micelles
still fully form and form around the nanoparticles when they are present, this means that
these variations of copolymer are extremely well suited for future usage in research. To
illustrate this point, the mPEG113 copolymers were assembled again with the addition of
the 5nm iron oxide nanoparticle. The effect of the nanoparticle on the final product size,
as shown when comparing Tables 2 and 4 with Tables 1 and 3, was to cause a small
change in the micelle diameter at around 25-30nm of increased diameter length. This
change is extremely small compared to the effect of changing the length of mPEG. The
increase in the assembled micelle’s diameter for the change in mPEG chain length from
113 to 45 results in an additional 300-700 nm as shown in Figure 15 where the error bar
of the copolymer mPEG45-b-p(L-Leu)20 demonstrates a wide range of sizes. This change
is more than ten times as large as the increase in size for the addition of the 5nm iron
oxide nanoparticles.
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As for the mPEG45 copolymer variants, their micelles’ diameters could easily
aggregate above and beyond 100 nm as shown in Table 1 and Table 3 as well as both
Figure 14 and Figure 15. As such, none of these copolymers were assembled utilizing the
5nm iron oxide nanoparticles, because to do so would be a waste of material. The goal is
to generate an amphiphilic block copolymer micelle encapsulating the nanoparticle with a
diameter of 100nm or less. The large size of the mPEG45 copolymers would only increase
with the addition of the nanoparticle. The copolymer mPEG45-b-p(L-Leu)6 did maintain a
consistent size below 100 nm, but a data trend cannot be easily derived from a single
point on a graph, so no nanoparticle was used there either. Therefore, it was deemed
unwise to continue to try to produce micelles in the desired size from the mPEG45
copolymer variants used here. However, the variation in size with changing amounts of
poly(L-Leucine) was more dramatic for these variations of copolymer, as shown by the
line for mPEG45 copolymers in Figure 14 and Figure 15. This is likely due to the
relatively smaller chain lengths of mPEG allowing the poly(L-Leucine) to account for a
larger mass fraction of the final product as well as tighter packing in the core of the
micelle, meaning the poly(L-Leucine) will have a larger effect on micelle diameter size
that isn’t completely eclipsed by the effect of mPEG.

3.2 HO-PEGn-b-p(L-Leu)x Copolymer Diameter Data
The second variation of poly(ethylene glycol) that was studied was known as αamino-ω-hydroxyl poly(ethylene glycol), or HO-PEG. Again, the ring-opening
polymerization of L-Leucine NCA was utilized to form a copolymer of HO-PEGn-b-p(LLeu)x so that its self-assembled micelles could be analyzed. Three different lengths of

26

HO-PEG were studied. The first two lengths were HO-PEG45 and HO-PEG113 in mimicry
of the earlier trials of mPEG. However, this time a third length of HO-PEG77 was used to
provide data of an intermediate length between the other two.
There were a few issues working with these HO-PEGn-b-p(L-Leu)x copolymers.
These copolymers possessed the consistency of fine powder, so obtaining a sample from
a larger batch through usage of a metal spatula wasn’t difficult in of itself. However, the
powder exhibited static electrical attraction to certain surfaces, so keeping it in one place
once collected was more difficult than the mPEG copolymers. Further comparison
between the two showed that HO-PEG copolymers were not as ready to dissolve in THF
as mPEG, often requiring some shaking to fully dissolve. Further complications could
result once the aqueous solution had been fully formed after the THF had evaporated.
Sometimes the copolymer stuck to the side of the vial as a ring and left behind water so
clear that there was nothing for the zetasizer to measure. Sometimes, visible flakes
formed overnight inside the mixture during the evaporation of THF. Surprisingly, these
flakes seemed to have no effect on zetasizer measurements when compared to well-mixed
solutions of the same copolymer. These complications in the aqueous solution appeared
more often with the addition of the 5nm iron oxide nanoparticle. Nevertheless, sufficient
data for aqueous solutions of the amphiphilic block copolymer micelles was obtained for
the analysis of the effects of polymer lengths and iron oxide nanoparticles on the
micelles’ size. As with the other copolymers, each individual self-assembly was
measured five times with the zetasizer. These measurements are shown in Table 5 and
Table 6.
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Table 3.5: Individual Measurements in Nanometers of Micelle Diameters Formed from
Copolymer Variations with 45, 77, or ~113 Monomeric Units of α-amino-ω-hydroxyl
polyethylene glycol (HO-PEG) and no 5 nm Nanoparticle
Tested Polymer
HO-PEG45-p(Leu)9
HO-PEG45-p(Leu)18
HO-PEG45-p(Leu)36

Trial 1
Trial 2
Trial 3
Trial 4
Trial 5
36.22
38.88
36.46
37.98
42.6
56.57
58.83
58.17
59.3
56.83
52.77
56.55
65.43
58.45
58.83

HO-PEG77-p(Leu)15
HO-PEG77-p(Leu)30
HO-PEG77-p(Leu)60

28.58
68.17
43.1

32.78
66.61
45.08

30.52
90.32
42.42

29.69
24
39.74

31.21
63.94
45.21

HO-PEG113-p(Leu)15
HO-PEG113-p(Leu)45

990
42.26

902.5
41.79

1090
43.47

1365
55.49

1083
39.62

Table 3.6: Individual Measurements in Nanometers of Micelle Diameters Formed from
Copolymer Variations with 45, 77, or ~113 Monomeric Units of α-amino-ω-hydroxyl
polyethylene glycol (HO-PEG) and 5 nm Nanoparticles
Tested Polymer
HO-PEG77-p(Leu)15
HO-PEG77-p(Leu)30
HO-PEG77-p(Leu)60
HO-PEG113-p(Leu)15
HO-PEG113-p(Leu)45

Trial 1
Trial 2
Trial 3
Trial 4
Trial 5
105.4
83.89
87.89
74.31
78.76
93.88
81.15
58.87
87.9
58.07
64.45
65.66
64.41
65.79
69.41
167.8
75.4

167.7
70.32

163.2
38.85

163.4
62.52

162.4
30.55

Once collected, the five data measurements for each copolymer variation were
averaged to find the mean diameter. This mean diameter was then compared with the
calculated mass fraction and monomer count of L-Leucine in the copolymer variation
used. The mean diameters and L-Leucine mass fractions are shown in Table 7 and Table
8.
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Table 3.7: Average Diameters and L-Leucine Mass Fractions for HO-PEGn-b-p(L-Leu)x
Copolymer Micelles that did not Contain Nanoparticles
Tested Copolymers
HO-PEG45-p(Leu)9
HO-PEG45-p(Leu)18
HO-PEG45-p(Leu)36

Mass Fraction of
Polydispersity Index
Average Diameter
Leucine
(PDI)
0.419
38.43 nm
33.35%
0.189
57.94 nm
50.02%
0.342
58.41 nm
66.88%

HO-PEG77-p(Leu)15
HO-PEG77-p(Leu)30
HO-PEG77-p(Leu)60

30.56 nm
62.61 nm
43.11 nm

33.04%
49.67%
66.25%

0.913
0.461
0.615

HO-PEG113-p(Leu)15
HO-PEG113-p(Leu)45

1086.1 nm
43.11 nm

66.25%
50.11%

0.615
0.314

Table 3.8: Average Diameters and L-Leucine Mass Fractions for HO-PEGn-b-p(L-Leu)x
Copolymer Micelles that were Made With 10 uL of 5 nm Nanoparticles
Tested Copolymers
HO-PEG77-p(Leu)15
HO-PEG77-p(Leu)30
HO-PEG77-p(Leu)60

Mass Fraction of
Polydispersity Index
Average Diameter
Leucine
(PDI)
0.276
86.05 nm
33.04%
0.266
75.97 nm
49.67%
0.338
65.94 nm
66.25%

HO-PEG113-p(Leu)15
HO-PEG113-p(Leu)45

164.9 nm
55.53 nm

66.25%
50.11%

0.338
0.318

One thing to note is that the results for HO-PEG113-b-p(L-Leu)15 without 5nm
nanoparticles also displayed a marked decrease in diameter to a tenth of the original size
with the addition of the iron oxide nanoparticles. Further evidence against the reliability
of these results is the PDI that was consistently above 0.5, which means that those results
are not very uniform in solution.
Scatterplots demonstrating comparisons of L-Leucine monomer count and LLeucine’s mass fraction vs. the final product diameter are shown in Figure 16 through
Figure 21. Figures 16 and 17 will display the results for the HO-PEG45 copolymers.
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Figures 18 and 19 will display the results for the HO-PEG77 copolymers. Figures 20 and
21 will display the results for the HO-PEG113 copolymers.

L-Leucine Count vs. Micelle Diameter for HO-PEG45-b-p(L-Leu)x
Copolymers
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Figure 3.3: A Direct Comparison of Mean HO-PEG45-b-p(L-Leu)x Copolymer Micelle
Diameter with the Number of L-Leucine Monomers
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Figure 3.4: Comparison of Mean HO-PEG45-b-p(L-Leu)x Copolymer Micelle Diameter
with the Mass Fraction of L-Leucine
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Figure 3.5: A Direct Comparison of Mean HO-PEG77-b-p(L-Leu)x Copolymer Micelle
Diameter with the Number of L-Leucine Monomers
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Figure 3.6: Comparison of Mean HO-PEG45-b-p(L-Leu)x Copolymer Micelle Diameter
with the Mass Fraction of L-Leucine
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Figure 3.7: A Direct Comparison of Mean HO-PEG113-b-p(L-Leu)x Copolymer Micelle
Diameter with the Number of L-Leucine Monomers
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Figure 3.8: A Direct Comparison of Mean HO-PEG113-b-p(L-Leu)x Copolymer Micelle
Diameter with the Number of L-Leucine Monomers

The structure of HO-PEG differs from mPEG in that the methoxy (CH3-O-) end
group on mPEG is exchanged for a hydroxy (H-O-) end group. This will increase the
hydrophilicity of the poly(ethylene glycol) because the hydroxy end group provides an H-
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bond for additional interactions with water. As this is a very small change on a polymer
that can be hundreds of repeat units long, the effect on the behavior of the copolymer and
the size of the micelles was expected to be minimal. However, there were significant
differences in behavior compared to the previous copolymer. The HO-PEGn-b-p(L-Leu)x
copolymer was electrostatic, resulting in attraction to the glass of its container. The
aqueous copolymer solution displayed altered behavior with the formation of flakes in
solution or a ring on the side glass. Furthermore, the primary trend of the mPEGn-b-p(LLeu)x copolymer in decreasing micelle size with increasing copolymer length, was not
observed for HO-PEGn-b-p(L-Leu)x. The data displayed in Figure 16 through Figure 21
clearly shows increasing diameters for HO-PEG45 and HO-PEG77 based copolymers
without the presence of the 5nm iron oxide nanoparticles. The iron oxide nanoparticles
seemed to reintroduce the decrease in diameter with increase in p(L-Leu) length for HOPEG77-b-p(L-Leu)x and HO-PEG113-b-p(L-Leu)x copolymers. However, HO-PEG45-bp(L-Leu)x copolymers did not receive the iron oxide nanoparticles as they were misplaced
in storage and have not been relocated yet.
When analyzing Figure 16 through Figure 21 to compare the HO-PEG chain
length’s effect on micelle diameter, it is found that the copolymer variations for HOPEG45-b-p(L-Leu)x and HO-PEG77-b-p(L-Leu)x without the 5nm iron oxide nanoparticle
are quite similar to each other in size according to Table 7, with all of their micelle
diameters lying between 30nm and 63nm. Without nanoparticles added, HO-PEG77-bp(L-Leu)30 possesses the largest diameter over the HO-PEG45-b-p(L-Leu)x variations at
62.61 nm. Furthermore, the error bars for HO-PEG77-b-p(L-Leu)30 with and without the
5nm nanoparticle are so large as to overlap over nearly 80 nm in the y-axis. Strangely,
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even with the large error bars, the copolymer maintains a diameter below 100 nm. That
being said, the other two measurements do show a decrease from HO-PEG45-b-p(L-Leu)x
micelle diameter to HO-PEG77-b-p(L-Leu)x micelle diameter. Interestingly, the addition
of the 5nm iron oxide nanoparticle resulted in HO-PEG77-p(L-Leu)15 obtaining an even
larger diameter of 86.05nm while HO-PEG77-p(L-Leu)30 only increased to 75.97 nm as
denoted in Table 8. The error bar for HO-PEG77-p(L-Leu)30 breaks past the 100 nm mark
in Figures 18 and 19, but it does not reach far enough down to account for the large
increase in size with the addition of the iron oxide nanoparticles. Repeat measurements of
HO-PEG77-b-p(L-Leu)30 were conducted, but the diameter maintained its large increase
with the addition of iron nanoparticles. It is possible that this particular copolymer
formula is inherently an exception to a general trend of decreasing size to increasing HOPEG length. As for the HO-PEG113-b-p(L-Leu)x variations. It is quite clear that HOPEG113-b-p(L-Leu)15 lies far outside the range of diameters for other variations and
should be considered an outlier. This judgment is supported by the fact that the other HOPEG113-b-p(L-Leu)x copolymer variations’ diameters lie much closer to the range of HOPEG45-b-p(L-Leu)x and HO-PEG77-b-p(L-Leu)x copolymer micelles’ diameters.
Discounting the 1083 nm diameter measurement, the copolymers made with HO-PEG113
still show an increased diameter from the other HO-PEG chain lengths according to
Table 7 and Table 8. It could be that the ideal length for HO-PEG in its block copolymers
is different than mPEG for its block copolymers, so HO-PEG113 will produce copolymer
micelles between 50 nm and 150 nm in diameter while mPEG113 delivers the most ideal
results in micelle diameter at under 20 nm in its diameter length.
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When examining the HO-PEG copolymer data, it was found that unlike the
mPEG copolymer variants, the only HO-PEG series to show a continuous decrease in
diameter size with an increase in Leucine count was the HO-PEG77 series with the
nanoparticle as shown in Figure 18 and Figure 19. However, even this measurement may
not be completely true. It is highly suspicious that the 5 nm nanoparticle, which
previously provided only a small increase of about 25-30 nm for mPEG copolymers and
an increase of about 13 nm for the other HO-PEG77 variants, would cause an increase of
about 50 nm in micelle diameter for HO-PEG77-b-p(L-Leu)15 between Table 7 without
the nanoparticles and Table 8 with the nanoparticles. Looking back at the individual
measurements in Table 5 and Table 6, the diameter of HO-PEG77-b-p(L-Leu)15 fluctuated
from about 50 nm to 100 nm in diameter, and the error bar representing this in Figure 18
and Figure 19 drives home the inconsistency in its size. The PDI for this copolymer was
also recorded as being above 0.5. This large variation may point to a variety of size in the
micelles formed, or it may be a sign of contamination that found its way into the trials of
that particular copolymer variant. However, since the trials including the nanoparticle
occurred some time after the measurements of the initial copolymer by itself, it is also
possible that the copolymer aged in that time and partially crystallized, leading to an
abnormally large diameter for that variant. Unfortunately for this theory, it is unclear why
only HO-PEG77-b-p(L-Leu)15 would age like this and not the other copolymers in the
series. Another possibility has to do with the addition of the nanoparticles themselves.
The prevailing method was to add the nanoparticles after filtering the THF solution, but it
was found that adding them beforehand did not appear to alter the size of the copolymer
micelles. Instances of unusable aqueous solutions of copolymer did increase alongside
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this discovery, but it was later found that the THF had aged. Once the THF had been
replaced with a fresh batch, the instances of unusable copolymer decreased considerably.
Accounting for the effect of increasing p(L-Leu) in the other HO-PEG copolymer
variations is virtually impossible. As shown in Figure 16 and Figure 17, the ranges of
error for the average diameters overlap for the latter two averages of HO-PEG45-b-p(LLeu)x copolymers. This is very strong evidence for no real change being evident so no
trends can be derived from the data. Once the outlier is removed from the HO-PEG113-bp(L-Leu)x data, its data points also do not change significantly with increasing p(L-Leu)
length. It can be derived from the data that the effect of p(L-Leu) length on the diameter
of the amphiphilic block copolymer micelles is that it doesn’t have an effect.
Aside from the HO-PEG113-b-p(L-Leu)15 that demonstrated an average measured
block copolymer micelle diameter of over 1000nm without the iron oxide nanoparticles
and an average diameter over 146 nm with the nanoparticles, every single variation of
HO-PEG copolymer utilized in this experiment possessed an average diameter under
100nm in size as shown in Table 7 and Table 8. However, the error bars for HO-PEG77p(L-Leu)30 do cross the line. Generally speaking, the addition of nanoparticles increased
the diameter of the nanoparticles by about 13-50nm in diameter flat. Taking percentage
increase instead, the addition of iron oxide nanoparticles could increase the diameter of
these nanoparticles by anywhere between 21.34% to over 100%. Compared to the more
stable increase of 20-30 nm or 44.35% to 72.41% in diameter for the addition of iron
oxide nanoparticles to the mPEGn-b-p(L-Leu)x copolymers, this seems to indicate that the
effect of the iron oxide nanoparticles on the copolymer variations for HO-PEGn-b-p(LLeu)x is more varying in its results. It is still consistently an increase in size, however.
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The fact that many of these copolymer variations remained under 100nm in diameter puts
every copolymer shown in the above figures in the position of being useful for further
research into their suitability for delivery into cells. However, it should be noted that
none of these copolymers outmatched mPEG113-b-p(L-Leu)65 for smallest average
diameter at 20.14 nm without the 5 nm iron oxide nanoparticle as shown in Table 3 or the
smallest average diameter at 47.03 nm while encapsulating the 5 nm iron oxide
nanoparticles. It should also be recognized that the HO-PEG copolymers had the highest
number of variations that were still in the acceptable range of below 100 nm in diameter
compared to either mPEGn-p(L-Leu)x or p(L-Leu)x-PEGn-p(L-Leu)x copolymers.

3.3 p(L-Leu)x-PEGn-p(L-Leu)x Copolymer Diameter Data
The ABA copolymers differ the most in structure from the base poly(ethylene
glycol) polymer. With an amine group on both ends poly(ethylene glycol) diamine
produces a copolymer that has two hydrophobic ends with a hydrophilic interior. This is
the inverse of where these polymers aggregate in an aqueous solution in that the
hydrophobic polymer will attempt to aggregate in the interior of the micelle and the
hydrophilic polymer will attempt to aggregate in the exterior. This change in structure is
expected to have a profound effect on the structure of the amphiphilic copolymer micelle
as shown in Figure 22.
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Figure 3.9: Expected Self-Assembly of an Amphiphilic ABA Block Copolymer Micelle
It is expected that the micelle of an amphiphilic ABA block copolymer will form
as the copolymers are bent in half to place both hydrophobic ends in the interior of the
micelle. Poly(ethylene glycol) is a very flexible polymer, so it will undergo the most
conformational change in the formation of the micelle in this proposed model. The
copolymer should not break since no bonds are cleaved in micelle formation. With the
copolymer expected to bend in half, as shown in the above figure, the overall length of
the copolymer is virtually halved, which may lead to a decreased micelle diameter as the
result of a thinner wall. In pursuit of this outcome, the ABA copolymer variations on p(LLeu)x-PEGn-p(L-Leu)x were assembled.
In comparison of the three main variations of the copolymers of poly(ethylene
glycol) and poly(L-Leu), the ABA copolymers were the most difficult to work with early
on. With a consistency far harder than the mPEG variations, it was very difficult to
measure out an appropriately sized sample without considerable effort. This toughness
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also garnered complication with dissolving the polymer in THF, which would greatly
lengthen the time it took for ABA polymers to get to fully dissolve in the solution.
Fortunately, the procedure after that point went smoothly with little to no complication.
The aqueous solutions displayed no irregularities after the 24-hour evaporation period for
the THF. The measurements of the micelles’ diameters were reasonably consistent in
each individual trial. However, these copolymers diverge from HO-PEG and mPEG
copolymers in terms of the data’s pattern. Rather than decrease in size overall as the
proportion of L-Leucine to ethylene glycol grows, there is an area where two of the
polymer types experience a sudden rise in micelle diameter length before shrinking back
down to an even smaller size. This trend could have arisen for two possible reasons. It is
possible that some contamination occurred in those solutions that was not present in the
other trials for other copolymer variations. It is also possible that the complicated physics
of ABA copolymers led to this divergence in the data’s pattern.
Five individual trials for each copolymer variation were averaged to find the mean
diameter. Furthermore, the mass fraction of L-Leucine was calculated for each of the
copolymer variations. The results of these calculations are shown in Table 11 and Table
12.
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Table 3.9: Average Diameters and L-Leucine Mass Fractions for ABA Copolymer
Micelles that did not Contain Nanoparticles
Tested Polymer
p(Leu)10-PEG45-p(Leu)10
p(Leu)20-PEG45-p(Leu)20

Polydispersity
Average Diameter Mass Fraction of Leucine Index (PDI)
0.170
76.97 nm
53.08%
566.9 nm
69.35%

p(Leu)5-PEG77-p(Leu)5
p(Leu)15-PEG77-p(Leu)15
p(Leu)30-PEG77-p(Leu)30
p(Leu)45-PEG77-p(Leu)45

468 nm
250 nm
950 nm
44.6 nm

24.84%
49.79%
66.48%
74.84%

p(Leu)22-PEG113-p(Leu)22
p(Leu)40-PEG113-p(Leu)40

146.8 nm
30.68 nm

49.78%
64.31%

0.409

Table 3.10: Average Diameters and L-Leucine Mass Fractions for ABA Copolymer
Micelles that were Made With 10 uL of 5n m Nanoparticles
Tested Polymer
p(Leu)22-PEG113-p(Leu)22
p(Leu)40-PEG113-p(Leu)40

Polydispersity
Average Diameter Mass Fraction of Leucine Index (PDI)
49.62 nm
49.78%
44.702 nm
64.31%

The lack of polydispersity indices is regrettable, but it was unavoidable as most of
this data is based on previous research done by Robert Mills, which was mostly removed
from the files of the computer that stored data from the Zetasizer.[18] The individual trials
were recovered and formed the error bars in the Figures that follow.
Only ABA copolymers with 113 monomers of PEG were treated with
nanoparticles due to the large size of the other variations in Table 11. The average
diameters were then compared to the count of L-Leucine monomers and the mass fraction
of L-Leucine through the creation of scatterplots with the micelle diameter in nm as the
y-axis and the L-Leucine count or mass fraction as the x-axis. The scatterplots
demonstrating this comparison are shown in Figure 22 through Figure 28.
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Figure 3.10: A Direct Comparison of Mean p(L-Leu)x-PEG45-p(L-Leu)x Copolymer
Micelle Diameter with the Number of L-Leucine Monomers
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Figure 3.11: Comparison of Mean p(L-Leu)x-PEG45-p(L-Leu)x Copolymer Micelle
Diameter with the Mass Fraction of L-Leucine
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Figure 3.12: A Direct Comparison of Mean p(L-Leu)x-PEG77-p(L-Leu)x Copolymer
Micelle Diameter with the Number of L-Leucine Monomers
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Figure 3.13: Comparison of Mean p(L-Leu)x-PEG77-p(L-Leu)x Copolymer Micelle
Diameter with the Mass Fraction of L-Leucine
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Figure 3.14: A Direct Comparison of Mean p(L-Leu)x-PEG113-p(L-Leu)x Copolymer
Micelle Diameter with the Number of L-Leucine Monomers

L-Leucine Mass Fraction vs. Micelle Diameter for
PEG113-p(L-Leu)x ABA Copolymers
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Figure 3.15: Comparison of Mean p(L-Leu)x-PEG113-p(L-Leu)x Copolymer Micelle
Diameter with the Mass Fraction of L-Leucine
Determining the data’s trend as the length of PEG increases in the ABA block
copolymers is relatively straightforward. The first two ABA block copolymer variations
with PEG45 and PEG77 display values for micelle diameters several hundred nanometers
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long as shown in Table 11. In contrast, the p(L-Leu)x-PEG113-p(L-Leu)x copolymer
micelles range only from 146.8nm in diameter to 30.68nm in diameter in the same Table.
However, each ABA block copolymer variation in PEG length did have at least one
copolymer variation that went below 100 nm in diameter. While it was first thought that
this was evidence of contamination for some of the trials, the numbers didn’t change
significantly even with repeated trials. Furthermore, the numbers do not vary very much
within the trials either, and this is represented by the relatively small error bars for the
various data points. The physics of ABA block copolymer micelle self-assembly has not
been studied as much as AB block copolymer self-assembly in literature, so there is no
confirmed explanation as of writing this thesis for why the sizes in the ABA block
copolymer diameters vary so wildly from one to the next. Because of the large variation
between the trials, no 5 nm iron oxide nanoparticle was utilized for the ABA copolymer
measurements that fell below 100 nm. Each variation of ABA copolymer would only
have received a single data point for assembly with the nanoparticles, and the results
would not have sufficient data to define a trend. However, both the severity of the
variations in the data and the size of the diameter seem to decrease with an increase in
PEG chain length.
The effect that the chain length of poly(L-Leucine) has on ABA block copolymer
micelle diameter is initially hard to see in the data, because as the chain length increases
the diameter increases and decreases by as much as 700 nm for 30 additional monomers
in total. It should be noted that while p(L-Leu)15-PEG77-p(L-Leu)15 is denoted as having
15 monomers of poly(L-Leucine) in the formula on either side, the total chain length of
poly(L-Leucine) is denoted as 30 monomers in the graphs above. Similar denotation
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holds true for the other ABA block copolymers. However, with no clear-cut data for
decrease or increase in diameter with the increase in poly(L-Leucine), the overall effect it
has is still unknown. The p(L-Leu)x-PEG77-p(L-Leu)x copolymers were given more trials
with four variations instead of two specifically to attempt find a logic to the data’s pattern
as shown in Figure 24 and Figure 25. Other than most diameters being several hundred
times 100 nm in size, there isn’t much of a pattern. Unless the change in size corresponds
to a wave rather than a simple curve or a line, there is no evidence of correlation between
p(L-Leu) length and amphiphilic block copolymer micelle diameter. Many more trials
would have to be carried out in future to fill out more data points to find the pattern of the
curve if a definable pattern is even attainable. One reason for the complexity of these
results can be found in how the ABA block copolymer micelles are expected to differ in
structure from the AB block copolymer micelles. AB block copolymer micelles form as
shown in Figure 2 back in the introduction, but ABA block copolymer micelles are
expected to form as the hydrophilic chain bends so that both hydrophobic chains are
contained in the interior of the micelle as shown in Figure 22. There’s another possibility
that may account for the unexpectedly large results for micelle diameter. If the chain is
not bent, then one hydrophobic end will be outside the interior of the micelle. Should this
happen enough times, other chains may aggregate to the exposed ends and vastly increase
the size of the micelle. More research would have to be done to make sure, yet it remains
that these copolymer micelle diameters are many times too large to be useful anyway.
Only p(L-Leu)x-PEG113-p(L-Leu)x copolymer variations were assembled with the
iron oxide nanoparticles, as shown in Table 10 and Table 12. This was largely due to the
high variation in diameter lengths for the ABA block copolymers, which prompted the
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question of whether it was wise to use the relatively expensive nanoparticles when there
were only singular polymers that could be tested as opposed to a group of similar
polymers in either PEG or poly(L-Leucine) chain length. Since the p(L-Leu)x-PEG113p(L-Leu)x copolymer variations possessed the smallest overall measurements, the
nanoparticles were added to them to see what would result. The fact that the smaller
diameter increased by about 50% comes as no surprise. However, the diameter for p(LLeu)15-PEG113-p(L-Leu)15 micelles shrank from 146.8nm to 49.62nm with the
introduction of the nanoparticles. This is a decrease in diameter by nearly 67% of the
original size! While this result is unexpected, a possible explanation for this decrease is
that the nanoparticles served as a stable starting point for the self-assembly process for
the micelles and attracted the hydrophobic chains so that no free hydrophobic ends were
present for further aggregation on to the micelle when it was complete. Nevertheless, for
both variations of p(L-Leu)x-PEG113-p(L-Leu)x copolymer micelles, the addition of the
nanoparticle produced results that were consistently under 100 nm in diameter. An
unexpected success.
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CHAPTER 4. CONCLUSION AND RECOMMENDATIONS FOR FUTURE
PROCEDURES
It is entirely possible to generate amphiphilic block copolymer micelles that fully
encapsulate 5 nm iron oxide nanoparticles while maintaining a diameter under 100 nm.
With a low PDI, it is also feasible to produce a population of these same micelles
suspended in aqueous solution. To demonstrate these possibilities, three varieties of
poly(ethylene glycol) were synthesized and copolymerized with poly(L-Leucine) to
produce three varieties of copolymer at various chain lengths. These poly(ethylene
glycol) and copolymer varieties were α-methoxy-ω-amino poly(ethylene glycol) to
produce mPEGn-b-p(L-Leu)x, α-amino-ω-hydroxyl poly(ethylene glycol) to produce HOPEGn-b-p(L-Leu)x, and poly(ethylene glycol) diamine to produce p(L-Leu)x-b-PEGn-bp(L-Leu)x.
The smallest diameters were provided by the mPEG113-b-p(L-Leu)x series of
copolymers as shown in Table 1 through Table 4. It has been established in earlier
research that the nanoparticle is still fully encapsulated even at the small size of a micelle
under 50nm in diameter.[18] Furthermore, the mPEGn-b-p(L-Leu)x copolymers were
easiest to work with in self-assembly for both weighing out a small sample and
suspension of said sample in solution. Because it is very promising, that series is highly
recommended for future research into copolymer micelle delivery systems.
The HO-PEGn-b-p(L-Leu)x copolymers were the most consistent of the three
varieties when it came to producing results that were below 100nm as shown in Table 5
through Table 8. Aside from a couple of exceptions, all of the tested HO-PEGn-b-p(LLeu)x copolymers fit the criteria. However, none of these copolymers outmatched the
mPEG113-b-p(L-Leu)x series in producing a micelle with the smallest diameter with or
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without the 5nm iron oxide nanoparticles. Due to the consistency of the HO-PEGn-b-p(LLeu)x results, this copolymer variation is also recommended for future research into
nanoparticle delivery via amphiphilic block copolymer micelles.
The amphiphilic ABA block copolymers produced from p(L-Leu)x-b-PEGn-b-p(LLeu)x are not recommended for future research. These copolymers are difficult to divide
into smaller samples due to the tough consistency of the product, and they are difficult to
fully dissolve and suspend in solution with THF. Furthermore, the results do not follow a
linear decrease for increasing chain lengths as the other copolymers do, and instead point
to either a more complicated relation or none at all.
With the recommended copolymer micelles below 100 nm in diameter, further
research should also be done on those micelles’ abilities to penetrate biological barriers.
A comparison between them may indicate which is most efficient at the task of biological
barrier penetration and nanoparticle delivery. Additional research is also recommended
for the testing of poly(ethylene glycol) copolymerized with other poly(amino acid)
variants. Poly(L-Leucine) was the only poly(amino acid) utilized in this study, but other
amino acids may yield different results. Another direction of research to consider would
be whether chemotactic signals can be introduced into the structure of the micelle. These
signals are often utilized by cells native to the living organism’s internal environment,
such as leukocytes, to assist in allowing those cells to move from one side of a biological
barrier to another through extravasation without triggering an immune response against
them.[12] Given that the amphiphilic block copolymer micelles already mimic cell walls to
shield their internal contents and go through extravasation, the additional aid of
chemotactic signals would be extremely helpful in furthering those capabilities.
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While bioengineered microorganisms may have the ability to deliver their
contents via infection, the lack of mutation or immune system response to block
copolymer micelles promises much greater results in the field of medicine. Further study
into their delivery capabilities is highly recommended by the results of this thesis.
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